AstraZeneca said its antibody-based cocktail to prevent and treat COVID was shown to retain neutralizing activity against Omicron coronavirus variants, including the highly contagious BA.2 sub-variant, in an independent lab study https://t.co/dFl8isE6yZ pic.twitter.com/3P4BZe7p0b— Reuters (@Reuters) March 21, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


